Sjögren-szindróma: vizsgálatok itt: Ausztrália
7 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Maroochydore
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - 2. fázisTaking peopleA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Where
- Nedlands, Southport
- Életkor
- 18 év to 100 év
- People
- 344 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00 - 1. fázisTaking peopleA Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
- Where
- Brisbane
- Életkor
- 18 év to 75 év
- People
- 63
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07649265 - 2. fázisTaking peopleA PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
- Where
- Brisbane, Maroochydore, Melbourne, Sydney
- Életkor
- 18 év to 80 év
- People
- 80
- Run by
- Lubris Bio Pty Ltd
See details and how to joinNCT07118241 - 1. fázisTaking peopleA Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
- Where
- Melbourne
- Életkor
- 18 év to 65 év
- People
- 105
- Run by
- Candid Therapeutics
See details and how to joinNCT07712939 - 1. fázisTaking peopleA Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
- Where
- Melbourne
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Xencor, Inc.
See details and how to joinNCT07284797 - 3. fázisTaking peopleA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Woodville South
- Életkor
- 18 év and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00